首页> 外文期刊>Nefrologia >Brachiobasilic arteriovenous fistula with superficialisation and transposition the basilic vein in a one stage surgical technique. Five years of single experience
【24h】

Brachiobasilic arteriovenous fistula with superficialisation and transposition the basilic vein in a one stage surgical technique. Five years of single experience

机译:一期外科手术技术中的腕管基底动脉动静脉瘘浅表化并置入基底静脉。五年单身经历

获取原文
获取外文期刊封面目录资料

摘要

BackgroundThe basilic vein is a deep vein which usually requires superficialisation and surgical transposition.Material and methodsThis is a retrospective study of 119 BBAVF-ST in patients with stage 5D chronic kidney disease who received an implant with a one-stage surgical technique (2011–2015). The percentage of primary (PP), assisted primary (APP) and secondary (SP) permeabilities were assessed, as well as the related complications. We analyzed the permeabilities using Kaplan–Meier survival curves and a univariate Log Rank analysis (Mantel–Cox).pvalues less than or equal to 0.05 were considered as significant.ResultsThe mean age of the study group was 67.9years, with 63.8% of the subjects being male. A total of 57 complications were detected during the follow-up period: 24 stenosis (42.1%), 11 thrombosis (19.2%), 7 vascular access steal syndromes (12.2%), 7 upper limb oedemas (12.2%), 6 post-puncture haematomas (10.5%) and 2 infections (3.5%). The percentages of PP obtained at 1, 6, 12 and 24months were 92.4%, 79.8%, 66.3% and 52%; APP: 94.1%, 87.3%, 80.4% and 65.6%, and SP: 95%, 89.1%, 84% and 67.5%, respectively. Diabetic patients presented with significantly worse permeabilities than vascular or idiopathic patients: (p=.037, .009 and .019, respectively).ConclusionsAccording to the results obtained in our study, the one-stage surgical implementation of BBAVF-ST presents high permeability rates and a small number of related complications. Diabetes mellitus is a factor related to a worse surgical prognosis. Some of the biggest advantages are the greater optimization of health resources and a shorter time in which the central venous catheter needs to remain in the body.
机译:背景基底静脉是深静脉,通常需要进行浅表化和手术移位。材料与方法这是对119 BBAVF-ST的5D慢性肾脏病患者的回顾性研究,该患者接受了单阶段手术技术的植入物(2011–2015) )。评估了原发性(PP),辅助性原发性(APP)和继发性(SP)通透性的百分比以及相关的并发症。我们使用Kaplan–Meier生存曲线和单变量Log Rank分析(Mantel–Cox)分析了渗透率。p值小于或等于0.05被认为是显着的。结果研究组的平均年龄为67.9岁,其中63.8%受试者是男性。随访期间共发现57例并发症:24例狭窄(42.1%),11例血栓形成(19.2%),7例血管通路窃取综合征(12.2%),7例上肢水肿(12.2%),6例术后穿刺血肿(10.5%)和2次感染(3.5%)。在1、6、12和24个月时获得的PP百分比分别为92.4%,79.8%,66.3%和52%; APP:94.1%,87.3%,80.4%和65.6%,SP:分别为95%,89.1%,84%和67.5%。糖尿病患者的通透性显着低于血管或特发性患者(分别为p.0.037,.009和.019)。结论根据我们的研究结果,BBAVF-ST的一期手术实施具有较高的通透性发生率和少量相关并发症。糖尿病是与手术预后较差有关的因素。一些最大的优点是更大程度地优化了健康资源,并缩短了需要将中央静脉导管留在体内的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号